1. Home
  2. CAG vs BLCO Comparison

CAG vs BLCO Comparison

Compare CAG & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$14.09

Market Cap

7.5B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.32

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAG
BLCO
Founded
1919
1853
Country
United States
Canada
Employees
26100
N/A
Industry
Packaged Foods
Ophthalmic Goods
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
5.9B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
CAG
BLCO
Price
$14.09
$16.32
Analyst Decision
Hold
Buy
Analyst Count
17
11
Target Price
$16.88
$18.45
AVG Volume (30 Days)
12.9M
358.5K
Earning Date
04-01-2026
04-29-2026
Dividend Yield
9.84%
N/A
EPS Growth
233.33
N/A
EPS
N/A
N/A
Revenue
$1,500,000,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
N/A
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$13.86
$10.83
52 Week High
$23.79
$18.92

Technical Indicators

Market Signals
Indicator
CAG
BLCO
Relative Strength Index (RSI) 33.75 51.18
Support Level $14.04 $16.26
Resistance Level $19.48 $17.11
Average True Range (ATR) 0.37 0.47
MACD 0.05 -0.02
Stochastic Oscillator 21.36 56.18

Price Performance

Historical Comparison
CAG
BLCO

About CAG ConAgra Brands Inc.

Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: